The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, October 13, 2020
The trial will evaluate the safety, tolerability and efficacy of an investigational anti-coronavirus H-Ig medicine for treating hospitalized adults at...
read more
Tuesday, October 13, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
The Native Antigen Company has announced the introduction of ten new monoclonal antibodies recognizing SARS-CoV-2, the causative agent of COVID-19.
read more
ARCA biopharma announced the FDA has approved the IND application for AB201 as a potential treatment for COVID-19.
read more
Eli Lilly and Company announced additional details on its SARS-CoV-2 neutralizing antibody programs.
read more
RedHill announced the U.S. Phase 2 study with opaganib in patients hospitalized with severe COVID-19 pneumonia has passed its second pre-scheduled ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Pfizer and BioNTech announced the initiation of a rolling submission to the EMA for BNT162b2, the lead candidate from the companies’ vaccine ...
read more
Thursday, October 08, 2020
Amphastar announced the FDA approved the Company’s ANDA for Atropine Sulfate injection 0.1mg/mL in the 10 mL Luer-Jet Prefilled Syringe System.
read more
Thursday, October 08, 2020
Corbus announced topline results from its 28-week Phase 2b study of lenabasum in patients with cystic fibrosis.
read more
Wednesday, October 07, 2020
BioMarin announced the FDA has granted Fast Track designation to BMN 307, an investigational gene therapy for the treatment of individuals with PKU.
read more
Tuesday, October 06, 2020
Researchers at Intermountain Healthcare in have developed a new clinical tool to accurately identify and diagnose COVID-19 patients at high risk of ...
read more
Tuesday, October 06, 2020
Synthetic Biologics announced the results of a planned interim futility analysis of the study of SYN-010 being conducted by Cedars-Sinai Medical ...
read more
Tuesday, October 06, 2020
AiViva Biopharma has begun dosing patients diagnosed with superficial or nodular basal cell carcinoma (BCC) with AIV001.
read more
Provention Bio announced the submission of the clinical module of the Company's BLA to the FDA for teplizumab, an investigational anti-CD3 monoclonal ...
read more